{
    "SPADE_UN_29735": {
        "Sequence Information": {
            "Peptide Name": "Neocryptolepine 9(PG)",
            "Sequence": "PG",
            "Sequence Length": 2,
            "Biological Activity": [
                "Anticancer",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [],
            "Literature": [
                {
                    "Title": "Synthesis and biological evaluation of new amino acid and dipeptide derivatives of neocryptolepine as anticancer agents.",
                    "Pubmed ID": "22574992",
                    "Reference": "J Med Chem. 2012;55:5077-5087",
                    "Author": "Sidoryk K, Switalska M, Wietrzyk J, Jaromin A, Pietka-Ottlik M, Cmoch P, Zagrodzka J, Szczepek W, Kaczmarek L, Peczynska-Czoch W",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/22574992"
                }
            ],
            "Mass": 172.18,
            "PI": 5.95,
            "Net Charge": 0,
            "Hydrophobicity": -1.0,
            "Frequent Amino Acids": "GP",
            "Absent Amino Acids": "ACDEFHIKLMNOQRSTUVWY",
            "Basic Residues": 0,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 0,
            "Polar Residues": 2,
            "Positive Residues": 0,
            "Negative Residues": 0,
            "SPADE ID": "SPADE_UN_29735",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_00002",
                    "Similarity": 1.0,
                    "Sequence": "WKSESVCTPGCVTGLLQTCFLQTITCNCKISK"
                },
                {
                    "SPADE_ID": "SPADE_N_00010",
                    "Similarity": 1.0,
                    "Sequence": "VTSKSLCTPGCITGVLMCLTQNSCVSCNSCIRC"
                },
                {
                    "SPADE_ID": "SPADE_N_00013",
                    "Similarity": 1.0,
                    "Sequence": "VTSWSLCTPGCTSPGGGSNCSFCC"
                }
            ],
            "Hemolytic Activity": "Mouse fibroblasts BALB/3T3:IC50=3.96±0.51 µM,Human erythrocytes:10% Hemolysis=300 µM",
            "Target Organism": "Human lung carcinoma A549(IC50=1.15±0.20µM),Human breast adenocarcinoma MCF-7(IC50=1.43±0.65µM),Human colon adenocarcinoma LoVo(IC50=0.98±0.02µM),Human carcinoma HeLa-KB(IC50=3.73±1.0µM)"
        }
    }
}